Affiliation:
1. Fundação Oswaldo Cruz, Brasil
2. Universidade de Brasília, Brasil
3. Universidade Federal do Rio Grande do Sul, Brasil
4. Universidade Federal do Ceará, Brasil
5. Universidade Federal de Santa Catarina, Brasil
6. Universidade Federal de São Paulo, Brasil
7. Universidade Federal de Pelotas, Brasil
Abstract
ABSTRACT OBJECTIVE To analyze the access to medicines to treat non-communicable diseases in Brazil according to socioeconomic, demographic, and health-related factors, from a multidimensional perspective. METHODS Analysis of data from the National Survey on Access, Use and Promotion of Rational Use of Medicines (PNAUM), household survey, sampling plan by conglomerates with representativeness of the Brazilian population and large areas of the country, according to sex and age domains. Data collected in 2013–2014 with sample of adults (≥ 20 years) who reported having non-communicable diseases and medical indication for use of medicines (n = 12,725). We assessed the prevalence of access to medicines for self-reported non-communicable diseases, considering four dimensions: availability, geographic accessibility, acceptability, and affordability. We applied Pearson’s Chi-square test to assess the statistical significance of the differences between strata, considering the level of significance of 5%. We found prevalence of 94.3%, 5.2%, and 0.5% for full, partial, and null access, respectively. Higher prevalence was observed among seniors in the South compared to the Northeast; for those who reported having one non-communicable disease compared to those who reported having two or more; for those who needed one medicine compared to those who needed three or more; and for those who self-assessed their health as good or very good. Geographic accessibility was similar in the Unified Health System and in the private pharmacies (72.0%). Total availability of medicines was 45.2% in the Unified Health System, 67.4% in the Popular Pharmacy Program, and 88.5% in private pharmacies. Acceptability was 92.5% in the Unified Health System, 97.8% in the Popular Pharmacy Program, and 98.7% in private pharmacies. As to affordability, 2.6% of the individuals failed to take the medicines they should in the 30-day period prior to the interview due to financial difficulty. Prevalence of full access to medicines for non-communicable diseases in Brazil is high and presents significant differences for age group, region of the country, number of non-communicable diseases, and for medicines prescribed and self-assessment of health. The major barriers to access to medicines were identified in the dimensions analyzed.
Subject
Public Health, Environmental and Occupational Health
Reference27 articles.
1. Prevalência e fatores associados ao acesso a medicamentos pela população idosa em uma capital do sul do Brasil: um estudo de base populacional;Aziz MM;Cad Saude Publica,2011
2. Acesso a medicamentos: direito ou utopia?;Bermudez JAZ,2014
3. Utilização de medicamentos em adultos: prevalência e determinantes individuais;Bertoldi AD;Rev Saude Publica,2004
4. Access to medicines from a health system perspective;Bigdeli M;Health Policy Plan,2013
5. Acesso a medicamentos medido no nível domiciliar: a proposta da OMS e outras iniciativas brasileiras;Blum B;Rev Bras Farm,2011
Cited by
39 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献